IVI RMA GLOBAL
Lynn Mason, DHA(c), MBA, is currently the Chief Executive Officer - North America at IVI RMA GLOBAL. Prior to this role, Lynn held various leadership positions in companies such as Broadstep Behavioral Health, ChenMed, CareServices LLC, DaVita Rx LLC, United Allergy Services, DaVita Kidney Care, Nestlé, and Morgan Stanley. Lynn holds an MBA from Stanford University Graduate School of Business and a BSBA in Accounting, Finance, and Anthropology from Washington University in St. Louis - Olin Business School.
This person is not in any offices
IVI RMA GLOBAL
3 followers
IVIRMA Global is the world’s premier fertility group that leads the industry in research, success rates and patient care. From clinical excellence, to research and innovation, to teaching the next generation of reproductive endocrinologists, to advancing cutting edge protocols, standards and practices in the field. The acronyms IVI and RMA represent the two best assisted reproduction groups in Europe and the U.S., respectively. Together, they have since the beginning of the nineties been setting the standard in the field of reproduction, until in February 2017 they decided to merge to form the largest Reproductive Medicine group in the world. IVI was founded in 1990 by Professors José Remohí and Antonio Pellicer, and became a leader in fertility treatment in Europe and Latin America. RMA was founded in 1999 by Drs. Paul Bergh, Richard Scott and Michael Drews, quickly becoming a leader in reproductive medicine in the United States. IVI and RMA both place great importance on research, high-quality scientific results, and a common culture with a single objective: to achieve the best results for patients. • 75 Clinical Offices & 28 Labs in 9 Countries • +465 Physicians & Embryologists • +2300 Employees • +100 babies born daily thanks to IVIRMA Research & Development… • +2500 Publications • 69 Researchers • 7 Researcher centers